Regencell Bioscience Holdings Ltd (RGC) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $26.29
• Market Cap: $12.79B
• EPS: $-0.01
• 52-Week High: $83.60
• 52-Week Low: $0.10

Market Sentiment

Regencell Bioscience Holdings Ltd currently has a Neutral sentiment score of -0.05.

About Regencell Bioscience Holdings Ltd

Regencell Bioscience Holdings Ltd is a biotechnology company focused on developing innovative therapeutic solutions that leverage advanced bioscience methodologies. Headquartered in Hong Kong, the company aims to address significant healthcare challenges through its proprietary research and development efforts. Regencell is positioned to capitalize on the growing demand for effective treatment alternatives in various medical sectors, offering institutional investors an opportunity to engage i...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Regencell Bioscience Holdings Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does RGC pay dividends?

Regencell Bioscience Holdings Ltd (RGC) does not currently pay a regular dividend.

What is RGC's market cap?

Regencell Bioscience Holdings Ltd (RGC) has a market capitalization of $12.79B with a current stock price of $26.29.